Bapineuzumab for mild to moderate Alzheimer's disease: a meta-analysis of randomized controlled trials
Volume:
Issue:
Year of Publication: 2017
Statistics
Citations : 2Authors : 0
Identifiers
Doi : 10.1186/s12883-017-0850-1SSN :
Volume:
Issue:
Year of Publication: 2017